AMERICA'S BIO AND PHARMA MANUFACTURING RENAISSANCE: WHERE DO WE GO FROM HERE?
September 15, 2020 ~ 1:00 - 4:00 PM

2020 AURP International Conference Pre-Session
Brought to you by AURP BIO Health Caucus

The Covid-19 Pandemic vividly demonstrates the need for rethinking ways to manufacture biological materials and create sustainable medical product supply lines for the United States. New program funding, new regulatory schemes and new community engagement are all solutions as we witness the renaissance of life science manufacturing in the US from Delaware to Alabama to California. Join a discussion of best bio and pharma manufacturing practices, public policies and programs to help the US respond to the Covid-19 Pandemic and create a more resilient manufacturing infrastructure.

Agenda
Click Here to Register
THANK YOU TO OUR SPEAKERS!
Mojdeh Bahar
Associate Director for Innovation and Industry Services
National Institute for Standards and Technology (NIST)
Chris Carlson
Senior Vice President
The Whiting-Turner Company
Arthur L. Edge III
Associate Director, Global Technical Operations
AstraZeneca (AZ)
Dr. Eric Edwards
Co-Founder and Chief Executive Officer
Phlow Corp. at VA Bio + Tech Park
Stephen Ezell
Vice President, Global Innovation Policy
Information Technology and Innovation Foundation (ITIF)
Patricia Larrabee
President
Facility Logix, LLC
Kelvin H. Lee
Director
National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Dr. Tyler Martin
Chief Executive Officer and Chairman
Adjuvance Technologies
Alex Philippidis
Senior News Editor
Genetic Engineering & Biotechnology News
Leslie Prewitt
Executive Director
BioTechnical Institute
Catherine Vorwald
Director of Life Sciences
Sterling Bay
Rich Bendis
Chief Executive Officer
BioHealth Innovation
Brian Darmody
Chief Executive Officer
AURP
Mark Romney 
Chief Industry Alliance Officer
UC Davis, Aggie Square


Thank you to our Sponsor!

 

Thank you to our BIO Health Caucus Chairs



Become a Sponsor!